Concussion-focused Scythian sets market debut
By GREGORY ZELLER // Scythian Biosciences Corp. is going public. The New York City/Toronto-based biotech, led by Great Neck investment banker Jonathan Gilbert on its quest to develop the world’s…
University of Miami
Financing set, cannabinoid-concussion study aims high
By GREGORY ZELLER // And now, onto the science. Canadian mining exploration company Kitrinor Metals Inc. and Scythian Biosciences Inc., a Calgary-based biotech owned by Great Neck investment banker Jonathan…
Stock deal locks funds for Scythian marijuana study
By GREGORY ZELLER // A Canadian R&D firm with Long Island roots has locked up the first tranche of a strategic investment that will fund a major study involving concussions…
Scythian, U of M concussion study hits the jack-pot
By GREGORY ZELLER // A Calgary-based R&D firm with strong Long Island ties has swung an eight-figure financing deal, lighting up a major study pitting cannabinoids against concussions. Scythian Biosciences…
Tackling concussions with cannabis
By GREGORY ZELLER // A research effort stretching from Florida to Long Island to Canada’s Alberta province will determine if compounds derived from marijuana can be effective treatments for concussions. Calgary-based R&D…